Finance

Lists
Why is ACHV down 3,18%?
Dive Deeper
ACHV:NASDAQ
Achieve Life Sciences Inc
7,01 $
-3,18%
(-0,23) 1D
6,99 $
-0,29% (-0,020)
After hours
Closed: 5 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACHV...
Open
7,24 $
High
7,34 $
Low
6,83 $
Mkt. cap
721,35 մլն
Avg. vol.
1,55 մլն
Volume
0,00
52-wk high
8,61 $
52-wk low
2,62 $
EPS
-1,55 $
Beta
2,30
Shares outstanding
102,90 մլն
No. of employees
28
Open
7,24 $
High
7,34 $
Low
6,83 $
Mkt. cap
721,35 մլն
Avg. vol.
1,55 մլն
Volume
0,00
52-wk high
8,61 $
52-wk low
2,62 $
EPS
-1,55 $
Beta
2,30
Shares outstanding
102,90 մլն
No. of employees
28
News stories
From web sources and news partners
About Achieve Life Sciences Inc
CEO-
Employees28
Founded1991
HeadquartersՍիեթլ, Վաշինգտոն, Միացյալ Նահանգներ
Sector-
Websiteir.achievelifesciences.com
Analyst ratings
Based on 6 analysts giving stock ratings to ACHV in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for ACHV in the last 3 months.
Highest
Current 7,01 $
18,00 $ (+156,78%)
Average
13,83 $ (+97,29%)
Lowest
10,00 $ (+42,65%)
Analyst
Recommendation
Action
Price target
Projected
Date
James Condulis
Stifel Nicolaus
Buy
Initiated
18,00 $
+156,8%
09/30/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
17,00 $
+142,5%
09/03/2026
Jason McCarthy
Maxim Group
Buy
Maintained
10,00 $
+42,7%
08/12/2026
Maxwell Skor
Morgan Stanley
Buy
Initiated
13,00 $
+85,4%
08/13/2026
Gary Nachman
Canaccord Genuity
Buy
Reiterated
13,00 $
+85,4%
08/12/2026
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
12,00 $
+71,2%
08/11/2026
Ryan Deschner
Raymond James
Buy
Initiated
20,00 $
+185,3%
06/26/2026
Mark Smith
Lake Street
Buy
Maintained
11,00 $
+56,9%
05/13/2026
Justin Walsh
JonesTrading
Buy
Reiterated
20,00 $
+185,3%
05/12/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
13,00 $
+85,4%
04/20/2026
Thomas Flaten
Lake Street
Buy
Maintained
11,00 $
+56,9%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5,32 մլն
3,87 մլն
3,29 մլն
3,81 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,37 մլն
10,86 մլն
7,17 մլն
14,58 մլն
Operating expense
14,69 մլն
14,73 մլն
10,46 մլն
18,39 մլն
Total operating expenses
14,69 մլն
14,73 մլն
10,46 մլն
18,39 մլն
Operating income
-14,69 մլն
-14,73 մլն
-10,46 մլն
-18,39 մլն
Other non operating income
-5,00 հզր
7,00 հզր
-13,00 հզր
-57,48 մլն
EBT including unusual items
-14,44 մլն
-14,66 մլն
-10,17 մլն
-74,77 մլն
EBT excluding unusual items
-14,34 մլն
-14,55 մլն
-10,45 մլն
-74,67 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14,44 մլն
-14,66 մլն
-10,17 մլն
-74,77 մլն
Net profit margin
-
-
-
-
Earnings per share
-0,28
-0,28
-0,19
-0,80
Interest and investment income
554,00 հզր
427,00 հզր
297,00 հզր
1,48 մլն
Interest expense
-192,00 հզր
-251,00 հզր
-274,00 հզր
-277,00 հզր
Net interest expenses
362,00 հզր
176,00 հզր
23,00 հզր
1,20 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-14,64 մլն
-14,67 մլն
-10,41 մլն
-18,34 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps